839
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Comorbid Pain and Opioid Addiction: Psychosocial and Pharmacological Treatments

, &
Pages 1536-1552 | Published online: 14 Jul 2011

REFERENCES

  • Adler, P., Good, M., Roberts, B., & Snyder, S. (2000). The effects of Tai Chi on older adults with chronic arthritis pain. Journal of Nursing Scholarship, 32, 377.
  • Alford, D. P., Compton, P., & Samet, J. H. (2006). Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Annals of Internal Medicine, 144, 127–134.
  • Amass, L., Kamien, J. B., & Mikulich, S. K. (2000). Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet. Drug & Alcohol Dependence, 58, 143–152.
  • Amass, L., Kamien, J. B., & Mikulich, S. K. (2001). Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans. Drug & Alcohol Dependence, 61, 173–181.
  • Arnold, R. M., Avants, S. K., Margolin, A., & Marcotte, D. (2002). Patient attitudes concerning the inclusion of spirituality into addiction treatment. Journal of Substance Abuse Treatment, 23, 319–326.
  • Avants, S. K., & Margolin, A. (1995). Self and addiction: The role of imagery in self-regulation. Journal of Alternative and Complementary Medicine, 1, 339–345.
  • Ballantyne, J. C., & LaForge, K. S. (2007). Opioid dependence and addiction during opioid treatment of chronic pain. Pain, 129, 235–255.
  • Barry, D. T., Beitel, M., Cutter, C. J., Joshi, D., Falcioni, J., & Schottenfeld, R. (2010). Conventional and nonconventional pain treatment utilization among opioid dependent individuals with pain seeking methadone maintenance treatment: A needs assessment study. Journal of Addiction Medicine, 4(2), 81–87.
  • Blinderman, C. D., Sekine, R., Zhang, B., Nillson, M., & Shaiova, L. (2009). Methadone as an analgesic for patients with chronic pain in methadone maintenance treatment programs (MMTPs). Journal of Opioid Management, 5, 107–114.
  • Brands, B., Blake, J., Sproule, B., Gourlay, D., & Busto, U. (2004). Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug and Alcohol Dependence, 73, 199–207.
  • Brennan, P. L., Schutte, K. K., & Moos, R. H. (2005). Pain and use of alcohol to manage pain: Prevalence and 3-year outcomes among older problem and non-problem drinkers. Addiction, 100, 777–786.
  • Brinkman, D. (1978). Biofeedback application to drug addiction in the University of Colorado drug rehabilitation program. International Journal of the Addictions, 13, 817–830.
  • Brown, R., Kraus, C., Fleming, M., & Reddy, S. (2004). Methadone: Applied pharmacology and use as adjunctive treatment in chronic pain. Postgraduate Medical Journal, 80, 654–659.
  • Bruce, R. (2006). Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: Implications and management for clinical practice. Journal of Acquired Immune Deficiency Syndrome, 41, 563–572.
  • Burke, B. L., Arkowitz, H., & Menchola, M. (2003). The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials. Journal of Consulting and Clinical Psychology, 71, 843–861.
  • Carroll, K. M., Rounsaville, B. J., Nich, C., Gordon, L. T., Wirtz, P. W., & Gawin, F. H. (1994). One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: Delayed emergence of psychotherapy effects. Archives of General Psychiatry, 51, 989–997.
  • Carson, J., Keefe, F., Lynch, T., Carson, K., Goli, V., Fras, A., (2005). Loving-kindness meditation for chronic low back pain: Results from a pilot trial. Journal of Holistic Nursing, 23, 287–304.
  • Centre for Addiction and Mental Health. (2001). Best practices: Concurrent mental health and substance abuse disorders. Ottawa: Health Canada.
  • Cheatle, M. D., & Gallagher, R. M. (2006). Chronic pain and comorbid mood and substance use disorders: A biopsychosocial treatment approach. Current Psychiatry Reports, 8, 371–376.
  • Collins, E. D., & Streltzer, J. (2003). Should opioid analgesics be used in the management of chronic pain in opiate addicts? American Journal on Addictions, 12, 93–100.
  • Compton, P., Darakjian, J., & Miotto, K. (1998). Screening for addiction in patients with chronic pain and “problematic” substance use: Evaluation of a pilot assessment tool. Journal of Pain and Symptom Management, 16, 355–363.
  • Compton, P., & Gebhart, G. F. (2003). The neurophysiology of pain and interfaces with addiction. In A. W. Graham (Ed.), Principles of addiction medicine (pp. 1385–1404). Chevy Chase, MD: American Society of Addiction Medicine.
  • Compton, W. M., & Volkow, N. D. (2006). Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence, 81, 103–107.
  • Cooper, J. R. (1995). Including narcotic addiction treatment in an office-based practice. Journal of the American Medical Association, 273, 1619–1620.
  • Cruciani, R. A., Sekine, R., Homel, P., Lussier, D., Yap, Y., Suzuki, Y., (2005). Measurement of QTc in patients receiving chronic methadone therapy. Journal of Pain and Symptom Management, 29, 385–391.
  • Currie, S. R., Hodgins, D. C., Crabtree, A., Jacobi, J., & Armstrong, S. (2003). Outcome from integrated pain management treatment for recovering substance abusers. Journal of Pain, 4, 91–100.
  • Daley, D. C., & Marlatt, G. A. (1992). Relapse prevention: Cognitive and behavioral interventions. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (pp. 533–542). Baltimore: Williams and Wilkins.
  • DHHS (Department of Health and Human Services, Drug Abuse Warning Network). (2004). National estimates of drug-related emergency department visits. Washington, DC: Author.
  • DiClemente, C. C., Schlundt, D., & Gemmell, L. (2004). Readiness and stages of change in addiction treatment. American Journal of Addiction, 13, 103–119.
  • Donald, M., Dower, J., & Kavanagh, D. J. (2005). Integrated versus nonintegrated management and care for clients with co-occurring mental health and substance abuse disorders: A qualitative systematic review of randomized controlled trials. Social Science & Medicine, 60, 1371–1383.
  • Dutra, L., Stathopoulou, G., Basden, S., Leyro, T., Powers, M. B., & Otto, M. (2008). A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry, 165, 179–187.
  • Eccleston, C. (2001). Role of psychology in pain management. British Journal of Anesthesia, 87, 144–152.
  • Elliott, A. M., Smith, B. H., Penny, K. I., Smith, W. C., & Chambers, W. A. (1999). The epidemiology of chronic pain in the community. Lancet, 354, 1248–1252.
  • Evers, A. W. M., Kraaimaat, F. W., Geenen, R., Jacobs, J. W. G., & Bijlsma, J. W. J. (2003). Pain coping and social support as predictors of long-term functional disability and pain in early rheumatoid arthritis. Behaviour Research and Therapy, 41, 1295–1310.
  • Ezzo, J., Berman, B., Hadhazy, V. A., Jadad, A. R., Lao, L., & Singh, B. B. (2000). Is acupuncture effective for the treatment of chronic pain? A systematic review. Pain, 86, 217–225.
  • Fiellin, D. A., Pantalon, M. V., Pakes, J. P., O'Connor, P. G., Chawarski, M., & Schottenfeld, R. S. (2002). Treatment of heroin dependence with buprenorphine in primary care. American Journal of Drug & Alcohol Abuse, 28, 231–241.
  • Fishbain, D. A., Rosomoff, H. L., Steele, R., & Rosomoff, R. (1992). Drug abuse, dependence, and addiction in chronic pain patients. Clinical Journal of Pain, 8, 77–85.
  • Flor, H., Knost, B., & Birbaumer, N. (2002). The role of operant conditioning in chronic pain: An experimental investigation. Pain, 95, 111–118.
  • Fordyce, W. E. (1976). Behavioral methods for chronic pain and illness. Saint Louis, MO: Mosby.
  • Fudala, P. J., Bridge, T. P., & Herbert, S. (1998). Buprenorphine/Naloxone Collaborative Study Group. A multisite efficacy evaluation of a buprenorphine/naloxone product for opiate dependence treatment. In L. S. Harris (Ed.), Problems of drug dependence (NIDA Research Monograph No. 179, pp. 105). Washington, DC: Government Printing Office.
  • Gatantino, M. L., Bzdewka, T. M., Eissler-Rnsso, J. L., Holbrook, M. L., Mogck, E. P., Geigle, P., (2004). The impact of modified Hatha Yoga on chronic low back pain: A pilot study. Alternative Therapies in Health & Medicine, 10, 56–59.
  • Gil, K. M., Ross, S. L., & Keefe, F. J. (1988). Behavioral treatment of chronic pain: Four pain management protocols. In R. D. France & R. Krishnan (Eds.), Chronic pain (pp. 376–413). Washington, DC: American Psychiatric Press.
  • Gilson, A. M., Ryan, K. M., Joranson, D. E., & Dahl, J. L. (2004). A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. Journal of Pain and Symptom Management, 28, 176–188.
  • Gonzalez, G., Oliveto, A., & Kosten, T. R. (2004). Combating opiate dependence: A comparison among the available pharmacological options. Expert Opinions in Pharmacotherapeutics, 5, 713–725.
  • Graham, N. A., Merlo, L. J., Goldberger, B. A., & Gold, M. S. (2008). Methadone and heroin-related deaths in Florida. American Journal of Drug and Alcohol Abuse, 34, 347–353.
  • Habib, S., Morrissey, S., & Helmes, E. (2005). Preparing for pain management: A pilot study to enhance engagement. Journal of Pain, 6, 48–54.
  • Hayes, S. C., Wilson, K. G., Gifford, E. V., Bissett, R., Piasecki, M., Batten, S. V., (2004). A preliminary trial of twelve-step facilitation and acceptance and commitment therapy with polysubstance-abusing methadone-maintained opiate addicts. Behavior Therapy, 35, 667–688.
  • Hojsted, J., & Sjogren, P. (2007). Addiction to opioids in chronic pain patients: A literature review. European Journal of Pain, 11, 490–518.
  • Huestis, M. A., Umbricht, A., & Preston, K. L. (1999). Safety of buprenorphine: No clinically relevant cardio-respiratory depression at high IV doses. In L. S. Harris (Ed.), Problems of drug dependence (pp. 62). Washington, DC: U.S. Government Printing Office.
  • Humphreys, K., Wing, S., McCarty, D., Chappel, J., Gallant, L., Haberle, B., (2004). Self-help organizations for alcohol and drug problems: Toward evidence-based practice and policy. Journal of Substance Abuse Treatment, 26, 151–158.
  • Ives, T. J., Chelminski, P. R., Hammett-Stabler, C. A., Malone, R. M., Perhac, J. S., Potisek, N. M., (2006). Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Services Research, 6, 46.
  • Johnson, R. E., Fudala, P. J., & Payne, R. (2005). Buprenorphine: Considerations for pain management. Journal of Pain and Symptom Management, 29, 297–326.
  • Jordan, J. (2006). Acupuncture treatment for opiate addiction: A systematic review. Journal of Substance Abuse Treatment, 30, 309–314.
  • Kabat-Zinn, J., Lipworth, L., Burney, R., & Sellers, W. (1986). Four-year follow-up of a meditation based program for the self-regulation of chronic pain: Treatment outcomes and compliance. Clinical Journal of Pain, 2, 159–173.
  • Keefe, F. J., Gil, K. M., & Rose, S. C. (1986). Behavioral approaches in the multidisciplinary management of chronic pain: Programs and issues. Clinical Psychology Review, 6, 87–113.
  • Khatami, M., Woody, G., O'Brien, C., & Mintz, J. (1982). Biofeedback treatment of narcotic addiction: A double-blind study. Drug and Alcohol Dependence, 9, 111–117.
  • Kosten, T. R., Morgan, C., & Kleber, H. D. (1991). Treatment of heroin addicts using buprenorphine. American Journal of Drug & Alcohol Abuse, 17, 119–128.
  • Kouyanou, K., Pither, C. E., & Wessely, S. (1997). Medication misues, abuse, and dependence in chronic pain patients. Journal of Psychosomatic Research, 43, 497–504.
  • Krantz, M. J., Lewkowiez, L., Hays, H., Woodroffe, M. A., Robertson, A. D., & Mehler, P. S. (2002). Torsade de pointes associated with very-high-dose methadone. Annals of Internal Medicine, 137, 501–504.
  • Krantz, M. J., Martin, J., Stimmel, B., Mehta, D., & Haigney, M. C. (2009). QTc interval screening in methadone treatment. Annals of Internal Medicine, 150(6), 387–395.
  • Kreek, M. J. (2000). Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Annals of the New York Academy of Science, 909, 186–216.
  • Kuhlman, J. J., Levine, B., Johnson, R. E., Fudala, P. J., & Cone, E. J. (1998). Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine. Addiction, 93, 549–559.
  • Lange, W. R., Fudala, P. J., Dax, E. M., & Johnson, R. E. (1990). Safety and side-effects of buprenorphine in the clinical management of heroin addiction. Drug and Alcohol Dependence, 26, 19–28.
  • Larson, M. J., Paasche-Orlow, M., & Cheng, D. M. (2007). Persistent pain is associated with substance use after detoxification: A prospective cohort analysis. Addiction, 102, 752–760.
  • Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., (1998). Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial. Addiction, 93, 475–486.
  • Mamtani, R., & Cimino, A. (2002). A primer of complementary and alternative medicine and its relevance in the treatment of mental health problems. Psychiatric Quarterly, 73, 367–381.
  • Margolin, A., Avants, S. K., & Kosten, T. R. (1994). Cue-elicited cocaine craving and autogenic relaxation. Association with treatment outcome. Journal of Substance Abuse Treatment, 11, 549–552.
  • Martell, B. A., Arnsten, J. H., Ray, B., & Gourevitch, M. N. (2003). The impact of methadone induction on cardiac conduction in opiate users. Annals of Internal Medicine, 139, 154–155.
  • Martell, B. A., O'Connor, P. G., Kerns, R. D., Becker, W. C., Morales, K. H., Kosten, T. R., (2007). Systematic review: Apioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Annals of Internal Medicine, 146, 116–127.
  • Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2003). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, CD002209.
  • Mayet, S., Farrell, M., Ferri, M. M. F., Amato, L., & Davoli, M. (2004). Psychosocial treatment for opiate abuse and dependence. Cochrane Database of Systematic Reviews, CD004330.
  • Meldrum, M. (2003). A capsule history of pain management. Journal of the American Medical Association, 290, 2470–2475.
  • Mertens, J. R., Lu, Y. W., Parthasarathy, S., Moore, C., & Weisner, C. M. (2003). Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO. Archives of Internal Medicine, 163, 2511–2517.
  • Miller, A., Hall, C., & Buchanan, R. (2004). The Texas medication algorithm project antipsychotic algorithm for schizophrenia: 2003 update. Journal of Clinical Psychiatry, 65, 500–508.
  • Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior. New York: Guilford Press.
  • Molton, I. R. G., Stoelb, C., & Jensen, B. L. (2007). Current psychological approaches to the management of chronic pain. Current Opinion in Anasthesiology, 20, 485–489.
  • Morley, S., Eccleston, C., & Williams, A. (1999). Systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy and behavior therapy for chronic pain in adults, excluding headache. Pain, 80, 1–13.
  • Morone, N. E., & Greco, C. M. (2007). Mind–body interventions for chronic pain in older adults: A structured review. Pain Medicine, 8, 359–375.
  • Mueser, K., Drake, R., & Wallach, M. (1998). Dual diagnosis: A review of etiological theories. Addictive Behaviors, 23, 717–734.
  • National Institutes of Health. (1998). NIH consensus development conference on acupuncture. Journal of the American Medical Association, 280, 1518–1524.
  • Neufeld, K., Kidorf, M., Kolodner, K., King, V., Clark, M., & Brooner, R. (2008). A behavioral treatment for opioid-dependent patients with antisocial personality. Journal of Substance Abuse Treatment, 34, 101–111.
  • Novick, D. M., Joseph, H., Salsitz, E. A., Kalin, M. F., Keefe, J. B., Miller, E. L., (1994). Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians’ offices (medical maintenance): Follow-up at three and a half to nine and a fourth years. Journal of General Internal Medicine, 9, 127–130.
  • Novick, D. M., Pascarelli, E. F., & Joseph, H. (1988). Methadone maintenance patients in general medical practice. A preliminary report. Journal of the American Medical Association, 259, 3299–3302.
  • Penzien, D. B., Rains, J. C., & Andrasik, F. (2002). Behavioral management of recurrent headache: Three decades of experience and empiricism. Applied Psychophysiology and Biofeedback, 27, 163–181.
  • Petry, N. M., Bickel, W. K., & Badger, G. J. (2001). Examining the limits of the buprenorphine interdosing interval: Daily, every-third-day and every-fifth-day dosing regimens. Addiction, 96, 823–834.
  • Petry, N. M., & Martin, B. (2002). Low-cost contingency management for treating cocaine- and opioid abusing methadone patients. Journal of Consulting and Clinical Psychology, 70, 398–405.
  • Portenoy, R. K. (1990). Chronic opioid therapy in non-malignant pain. Journal of Pain and Symptom Management, 5, S46–S62.
  • Potter, J., Shiffman, S., & Weiss, R. (2008). Chronic pain severity in opioid-dependent patients. American Journal of Drug and Alcohol Abuse, 34, 101–107.
  • Prater, C. D., Zylstra, R. G., & Miller, K. E. (2002). Successful pain management for the recovering addicted patient. Primary Care Companion to the Journal of Clinical Psychiatry, 4, 125–131.
  • Prochaska, J. O., & DiClemente, C. C. (1986). Toward a comprehensive model of change. In W. R. Miller & N. Heather (Eds.), Treating addictive behavior: Processes of change (pp. 3–27). New York: Plenum Press.
  • Purdue Pharma. (2009). FDA advisory committee briefing document on NDA 22-272 (reformulated OxyContin® tablets). Retrieved November 4, 2009, from http://www.fda.gov/downloads/AdvisoryCommittees/Committe esMeetingMaterials/Drugs/AnestheticAndLifeSupportDrugsAd visoryCommittee/UCM183205.pdf
  • Rance, M. J., & Dickens, J. N. (1978). The influence of drug-receptor kinetics on the pharmacological and pharmaco-kinetic profiles of buprenorphine. In J. M. Van Ree & L. Pereniums (Eds.), Characteristics and function of opioids (pp. 65–66). Amsterdam: Elsevier/North-Holland Biomedical Press.
  • Rau, J., Ehlebracht-König, I., & Petermann, F. (2008). Impact of a motivational intervention on coping with chronic pain: Results of a controlled efficacy study [abstract only; article in German]. Schmerz, 22, 575–578, 580–585.
  • Reiger, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association, 19, 2511–2518.
  • Reilly, R. L. (1994). Adapting the twelve-step approach to chronic pain. Behavioral Health Management, 14, 2.
  • Resnick, R. B., Galanter, M., Pycha, C., Cohen, A., Grandison, P., & Flood, N. (1992). Buprenorphine: An alternative to methadone for heroin dependence treatment. Psychopharmacology Bulletin, 28, 109–113.
  • Resnick, R. B., Resnick, E., & Galanter, M. (1991). Buprenorphine responders: A diagnostic subgroup of heroin addicts? Progress in Neuro-Psychopharmacology & Biological Psychiatry, 15, 531–538.
  • Rhodin, A., Gronbladh, L., Nilsson, L. H., & Gordh, T. (2006). Methadone treatment of chronic non-malignant pain and opioid dependence: A long-term follow-up. European Journal of Pain, 10, 271–278.
  • Roper-Starch Worldwide. (1999). Chronic pain in America: Roadblocks to relief. Retrieved March 18, 2009, from http://www.ampainsoc.org/links/roadblocks/index.htm#toc.
  • Rosenblum, A., Joseph, H., Fong, C., Kipnis, S., Cleland, C., & Portenoy, R. K. (2003). Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. Journal of the American Medical Association, 289, 2370–2378.
  • Rosenzweig, S., Greeson, J. M., Reibel, D. K., Green, J. S., Jasser, S. A., & Beasley, D. (2010). Mindfulness-based stress reduction for chronic pain conditions: Variation in treatment outcomes and role of home meditation practice. Journal of Psychosomatic Research, 68, 29–36.
  • Rounsaville, B. J., & Carroll, K. M. (1997). Individual psychotherapy for drug abusers. In J. H. Lowinsohn, P. Ruiz, & R. B. Miller (Eds.), Comprehensive textbook of substance abuse (pp. 430–439). New York: Williams & Wilkins.
  • Rounsaville, B. J., & Kleber, H. D. (1985). Psychotherapy/ counseling for opiate addicts: Strategies for use in different treatment settings. International Journal of Addiction, 20, 869–896.
  • Rubak, S., Sandbaek, A., & Lauritzen, T. (2005). Motivational interviewing: A systematic review and meta-analysis. British Journal of General Practice, 55, 305–312.
  • SAMSHA. (2002). Report to congress on the prevention and treatment of co-occurring substance abuse disorders and mental disorders. Rockville, MD: US Department of Health and Human Services.
  • SAMSHA. (2005). Assessment and treatment of patients with coexisting mental illness and alcohol and other drug abuse. Treatment improvement protocol (TIP) series. Rockville, MD: US Department of Health and Human Services
  • Savage, S. R. (2002). Assessment for addiction in pain treatment settings. Clinical Journal of Pain, 18, S28–S38.
  • Savage, S. R., Joranson, D. E., Covington, E. C., Schnoll, S. H., Heit, H. A., & Gilson, A. M. (2003). Definitions related to the medical use of opioids: Evolution towards universal agreement. Journal of Pain and Symptom Management, 26, 655–667.
  • Seybold, K. (2007). Physiological mechanisms involved in religiosity/spirituality and health. Journal of Behavioral Medicine, 30, 303–309.
  • Silverman, S. M. (2009). Opioid induced hyperalgesia: Clinical implications for the pain practitioner. Pain Physician, 12, 679–684.
  • Stetter, F., & Kupper, S. (2002). Autogenic training: A meta-analysis of clinical outcome studies. Applied Psychophysiology and Biofeedback, 27, 45–98.
  • Stitzer, M. L., Iguchi, M. Y., & Felch, L. J. (1992). Contingent take-home incentives: Effects on drug use of methadone maintenance patients. Journal of Consulting and Clinical Psychology, 60, 927–934.
  • Stitzer, M., & Petry, N. (2006). Contingency management for treatment of substance abuse. Annual Review of Clinical Psychology, 2, 411–434.
  • Streltzer, J., & Kosten, T. R. (2003). Methadone maintenance therapy and chronic pain [letter]. Journal of the American Medical Association, 290, 2403.
  • Syrjala, K. L., Donaldson, G. W., Davis, M. W., Kippes, M. E., & Carr, J. E. (1995). Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: A controlled clinical trial. Pain, 63, 189–198.
  • Tunks, E. R., Crook, J., & Weir, R. (2008). Epidemiology of chronic pain with psychological comorbidity: Prevalence, risk, course, and prognosis. Canadian Journal of Psychiatry, 53, 224–234.
  • Turk, D. C. (2008). Perspectives on chronic pain: The role of psychological factors. Current Directions in Psychological Science, 3, 45–48.
  • Turner, J. A., & Clancy, S. (1988). Comparison of operant behavioral and cognitive-behavioral group treatment for chronic low back pain. Journal of Consulting and Clinical Psychology, 56, 261–266.
  • Vallejo, Z., & Amaro, H. (2009). Adaptation of mindfulness-based stress reduction program for addiction relapse prevention. The Humanistic Psychologist, 37, 192–206.
  • Wachholtz, A. B., & Pargament, K. (2005). Is spirituality a critical ingredient of meditation? Comparing the effects of spiritual meditation, secular meditation, and relaxation on spiritual, psychological, cardiac, and pain outcomes. Journal of Behavioral Medicine, 28, 369–384.
  • Wachholtz, A. B., & Pargament, K. (2008). Migraines and meditation: Does spirituality matter? Journal of Behavioral Medicine, 31, 351–366.
  • Wachholtz, A. B., Pearce, M., & Koenig, H. (2007). Exploring the relationship between spirituality, coping, and pain: Past research and future directions. Journal of Behavioral Medicine, 30, 311–318.
  • Walsh, S. L., Preston, K. L., Bigelow, G. E., & Stitzer, M. L. (1995). Acute administration of buprenorphine in humans: Partial agonist and blockade effects. Journal of Pharmacology & Experimental Therapeutics, 274, 361–372.
  • Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994). Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clinical Pharmacology & Therapeutics, 55, 569–580.
  • Ward, J., Bell, J., & Mattick, R. P. (1996). Methadone maintenance therapy for opioid dependence: A guide to appropriate use. In J. Ward, R. P. Mattick, & W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 440–449). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  • Webster, L. R., & Webster, R. M. (2005). Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the opioid risk tool. Pain Medicine, 6, 432–442.
  • Weinstein, S. M., Laux, L. F., Thornby, J. I., Lorimor, R. J., Hill, C. S., Thorpe, D. M., (2000). Physicians’ attitudes toward pain and the use of opioid analgesics: Results of a survey from the Texas cancer pain initiative. Southern Medical Journal, 93, 479–487.
  • Weissman, D. E., & Haddox, J. D. (1989). Opioid pseudoaddiction. Pain, 36, 363–366.
  • Woody, G. E., McLellan, A. T., Luborsky, L., & O'Brien, C. P. (1987). Twelve-month follow-up of psychotherapy for opiate dependence. American Journal of Psychiatry, 144, 590–596.
  • Zgierska, A., Rabago, D., Chawla, N., Kushner, K., Koehler, R., & Marlatt, A. (2009). Mindfulness meditation for substance use disorders: A systematic review. Substance Abuse, 30, 266–294.
  • Ziedonis, D. M. (2004). Integrated treatment of co-occurring mental illness and addiction: Clinical intervention, program, and system perspectives. CNS Spectrum, 9, 892–904.
  • Ziedonis, D. M., Berman, J., Lehn, M. D., & Coameco, S. (2008). Support groups and twelve-step programs in the treatment of the chronic pain patient. In H. S. Smith & S. D. Passik (Eds.), Pain and chemical dependency (pp. 271–284). New York: Oxford University Press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.